News

BIOTECanada article about CIMTEC customer KalGene Pharmaceuticals

The National Research Council and KalGene Pharmaceuticals recently announced an agreement to co-develop a new treatment against aggressive...

CIMTEC Chief Scientific Officer and Centre Director, Dr. Aaron Fenster, meeting with customers, 3D NerveVision

London, Ontario, September 10, 2014 – “Clinical testing has been one of the biggest barriers to developing new imaging technology for...

Sheep's kidney showing saline injection site imaged by OxEMA system

Earlier tumour diagnosis with advanced ultrasound technology from Oxford University TORONTO –Isis Innovation, the technology transfer arm...

NRC and KalGene Pharmaceuticals announce an agreement to co-develop a new treatment against aggressive brain cancers

Ottawa, Ontario, July 21, 2014 - The National Research Council of Canada (NRC) and KalGene Pharmaceuticals are proud to announce an...

Biotechnology Focus, CIMTEC launches spin-off company Focal Healthcare, Inc.

Biotechnology Focus, July 11, 2014 Focal Healthcare (Focal) was founded as a spin-off company out of the Centre for Imaging Technology...

KalGene Pharmaceuticals partners with CIMTEC

London, Ontario, June 12, 2014 – KalGene Pharmaceuticals, Inc. (KalGene) is expediting development of a prognostic marker and companion...

CIMTEC is one of Canada China Business Council’s newest members.  “The Canada China Business Council (CCBC) is the country’s Canada-China...

March 2014 edition of Canadian Healthcare Technology

Canadian Healthcare Technology, March 2014 The Centre for Imaging Technology Commercialization (CIMTEC) was founded in 2011 to facilitate...

Dear Company Representative: Ontario Trade Mission to AdvaMed 2014 This is a “heads up” to advise you that the Trade Branch of the Ontario...

CIMTEC in Business London Magazine, January 2014

The January 2014 edition of Business London Magazine includes an article about CIMTEC.  

Pages